SUNIL AGARWAL

CIK 1616640 · EVP, Head of Development & CMO · last filed 2026-01-23

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$4.61M

Companies

7

Total Filings

53

Lifetime Open-Market Net

-$4.28M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Astria Therapeutics, Inc. (ATXS) Delisted Director $12.58 $0 3 2026-01-23
ARVN Director 30,166 $7.58 $228.7K $0 3 2025-06-30
CALA Director $0.00 $0 8 2022-06-03
SANA EVP, Head of Development & CMO 1,551,627 $2.68 $4.16M -$1.56M 4 2022-03-08
MyoKardia, Inc. (MYOK) Delisted Director 2,300 $0 8 2020-06-23
Juno Therapeutics, Inc. (JUNO) Delisted President of R & D 35,893 -$326.1K 5 2018-03-07
RARE Chief Medical Officer 9,136 $24.35 $222.5K -$2.39M 21 2016-08-23

Recent Filings · Page 6 of 6

53 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2015-08-21 RARE Mixed −12,500 -$1.97M EDGAR
2015-05-27 RARE Grant (A) +4,400 $0 EDGAR
2014-08-21 RARE Grant (A) +25,000 $0 EDGAR
Showing 5153 of 53
Page 6 of 6
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.